Search

everythinglearnresearchcommunity

for

Search:↓

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Combination therapies might work better for some vitiligo patients, but results vary.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Herbal medicine might be a good alternative for treating hair loss.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.